2016年ACR-EULAR肌炎应答标准的以患者为中心的评估:评价应答的意义
本研究为前瞻性研究,纳入50例成人肌炎患者(多发性肌炎6例、皮肌炎24例、坏死性肌病9例、抗合成酶综合征11例;平均年龄52岁,女性占60%),在基线和6个月时采集6项核心指标和患者中心结局指标。21例患者在6个月时达到TIS改善标准;达到最低TIS改善的患者在疲劳、疼痛、生活质量、体力活动和躯体功能方面的改善显著大于无改善者,且TIS与多数患者中心结局指标呈中至强相关;结论支持将TIS作为有临床意义的改善指标。
要点
- 50例成人肌炎患者中21例在6个月时达到TIS改善标准。
- 最低TIS改善组在疲劳、疼痛、生活质量、体力活动和躯体功能方面的改善显著大于无改善组。
- TIS与多数患者中心结局指标呈中至强相关。
核心结论
- 达到TIS改善标准伴随着疲劳、疼痛、健康相关生活质量、躯体功能和体力活动的显著临床改善。
- 作者认为这些结果支持将TIS作为有临床意义的改善指标。
研究设计与样本
- 前瞻性研究,纳入50例成人肌炎患者(多发性肌炎6例、皮肌炎24例、坏死性肌病9例、抗合成酶综合征11例;平均年龄52岁,女性占60%)。
- 基线及6个月访视时采集6项核心指标和患者中心结局指标。
- 采用Mann-Whitney U检验比较改善组间的患者中心结局指标,采用Spearman相关和回归模型分析TIS与患者中心结局指标的相关性和关联。
主要发现
- 50例患者中21例在6个月时满足TIS改善标准。
- 达到最低TIS改善的患者在疲劳、疼痛、生活质量、体力活动和躯体功能方面的改善显著大于无改善者。
- 达到中度至重大TIS改善时,患者中心结局指标的改善更大。
- TIS与多数患者中心结局指标呈中至强相关。
关键数值与推荐
- TIS为使用肌炎核心指标变化计算的复合指标。
- 患者中心结局指标包括疲劳(视觉模拟量表和SF-36)、疼痛(视觉模拟量表和SF-36)、健康相关生活质量(SF-36)、躯体功能(PROMIS-躯体功能、SF-36、坐立试验、起立行走计时试验和6分钟步行)及体力活动(活动记录仪)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The ACR-EULAR Myositis Response Criteria [Total Improvement Score (TIS)] is a composite measure calculated using changes in myositis core set measures. It is unclear if achieving improvement per TIS reflects improvement in any symptoms of patients with myositis. In this study, we examined the association between achieving TIS improvement and patient-centred outcome measures (PCOMs). METHODS: Adults with myositis were enrolled in a prospective study with baseline and 6-month visits. Six core set measures were collected at each visit along with the following PCOMs: fatigue [visual analogue scale (VAS) and short form 36 (SF36)], pain (VAS, SF36), health-related quality of life (SF-36), physical function (PROMIS-physical function, SF36, sit-to-stand, timed up-and-go and six-min walk) and physical activity (actigraphy). Mann-Whitney U was used to compare PCOMs between improvement groups. Spearman correlation and regression models were used for correlation and association between TIS and PCOMs, respectively. RESULTS: Of 50 patients (six polymyositis, 24 dermatomyositis, nine necrotizing myopathy, 11 anti-synthetase syndrome) enrolled (mean age: 52, 60% female), 21 patients satisfied the TIS improvement criteria at 6 months. PCOMs including fatigue, pain, quality of life, physical activity and physical function demonstrated significantly greater improvement in patients who had minimal TIS improvement compared with those with no improvement. Greater PCOM improvements were seen with moderate-major TIS improvement. TIS had moderate-strong correlations with most PCOMs. CONCLUSION: Achieving improvement criteria was accompanied by significant clinical improvements in fatigue, pain, health-related quality of life, physical function, and physical activity. These results support the use of TIS as a clinically meaningful metric of improvement.
引用
- Saygin D, Chandrasekhara Pillai A, Moghadam-Kia S, et al. A patient-centred assessment of the 2016 ACR-EULAR Myositis Response Criteria: evaluating the meaningfulness of responses. Rheumatology (Oxford). 2025. PMID: 38460544. doi:10.1093/rheumatology/keae143
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。